{"id":"https://openalex.org/W2016487555","doi":"https://doi.org/10.1002/hep.25580","title":"Inhibition of hepatic sulfatase-2 In Vivo : A novel strategy to correct diabetic dyslipidemia","display_name":"Inhibition of hepatic sulfatase-2 In Vivo : A novel strategy to correct diabetic dyslipidemia","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-11","ids":{"openalex":"https://openalex.org/W2016487555","doi":"https://doi.org/10.1002/hep.25580","mag":"2016487555","pmid":"https://pubmed.ncbi.nlm.nih.gov/22234891","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3345297"},"language":"en","primary_location":{"id":"doi:10.1002/hep.25580","doi":"https://doi.org/10.1002/hep.25580","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hep.25580","pdf_url":null,"source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016487555"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3345297","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022082916","display_name":"Carlijne Hassing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Carlijne H. Hassing","raw_affiliation_strings":["Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands","fax: +31 30 5669343"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]},{"raw_affiliation_string":"fax: +31 30 5669343","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078587396","display_name":"Hans L. Mooij","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans Mooij","raw_affiliation_strings":["Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102856350","display_name":"Shuling Guo","orcid":"https://orcid.org/0000-0001-6703-9303","observed_orcids":["https://orcid.org/0000-0001-6703-9303"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shuling Guo","raw_affiliation_strings":["Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044334898","display_name":"Brett P. Monia","orcid":"https://orcid.org/0000-0002-7473-1012","observed_orcids":["https://orcid.org/0000-0002-7473-1012"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brett P. Monia","raw_affiliation_strings":["Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101963769","display_name":"Keyang Chen","orcid":"https://orcid.org/0000-0003-3019-577X","observed_orcids":["https://orcid.org/0000-0003-3019-577X"]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keyang Chen","raw_affiliation_strings":["Section of Endocrinology, Diabetes and Metabolism, Temple University School of Medicine, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Endocrinology, Diabetes and Metabolism, Temple University School of Medicine, Philadelphia, PA","institution_ids":["https://openalex.org/I84392919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050017510","display_name":"Wim Kulik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wim Kulik","raw_affiliation_strings":["Laboratory of Genetic and Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Genetic and Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060583173","display_name":"Geesje M. Dallinga\u2010Thie","orcid":"https://orcid.org/0000-0001-5412-5923","observed_orcids":["https://orcid.org/0000-0001-5412-5923"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Geesje M. Dallinga-Thie","raw_affiliation_strings":["Department of Experimental Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands","Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]},{"raw_affiliation_string":"Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040981713","display_name":"Max Nieuwdorp","orcid":"https://orcid.org/0000-0002-1926-7659","observed_orcids":["https://orcid.org/0000-0002-1926-7659"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Max Nieuwdorp","raw_affiliation_strings":["Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081557648","display_name":"Erik S.G. Stroes","orcid":"https://orcid.org/0000-0001-9555-6260","observed_orcids":["https://orcid.org/0000-0001-9555-6260","https://orcid.org/0009-0000-7584-7677"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Erik S.G. Stroes","raw_affiliation_strings":["Cosenior authors","Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cosenior authors","institution_ids":[]},{"raw_affiliation_string":"Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023474681","display_name":"Kevin Jon Williams","orcid":"https://orcid.org/0000-0002-0000-2159","observed_orcids":["https://orcid.org/0000-0002-0000-2159"]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kevin Jon Williams","raw_affiliation_strings":["Cosenior authors","Section of Endocrinology, Diabetes and Metabolism, Temple University School of Medicine, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cosenior authors","institution_ids":[]},{"raw_affiliation_string":"Section of Endocrinology, Diabetes and Metabolism, Temple University School of Medicine, Philadelphia, PA","institution_ids":["https://openalex.org/I84392919"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5022082916"],"corresponding_institution_ids":["https://openalex.org/I2802928900"],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":null,"fwci":4.5624,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":{"value":0.95523286,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"55","issue":"6","first_page":"1746","last_page":"1753"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.8759999871253967,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.8759999871253967,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.046300001442432404,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.015399999916553497,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulfatase-2","display_name":"SULF2","score":0.8790000081062317},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9419999718666077},{"id":"https://openalex.org/keywords/diabetic-dyslipidemia","display_name":"diabetic dyslipidemia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/postprandial-hypertriglyceridemia","display_name":"postprandial hypertriglyceridemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/heparan-sulfate-proteoglycans","display_name":"heparan sulfate proteoglycans","score":0.9169999957084656},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9390000104904175},{"id":"https://openalex.org/keywords/db-db-mice","display_name":"db/db mice","score":0.8529999852180481},{"id":"https://openalex.org/keywords/hepatic-lipoprotein-uptake","display_name":"hepatic lipoprotein uptake","score":0.7459999918937683},{"id":"https://openalex.org/keywords/triglyceride-rich-lipoproteins","display_name":"triglyceride-rich lipoproteins","score":0.800000011920929},{"id":"https://openalex.org/keywords/hepatic-gene-expression","display_name":"hepatic gene expression","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8377647995948792},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8202797174453735},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.7215108275413513},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.5599267482757568},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5406444072723389},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5263375639915466},{"id":"https://openalex.org/C2778041096","wikidata":"https://www.wikidata.org/wiki/Q424668","display_name":"Heparan sulfate","level":3,"score":0.4915967881679535},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.4903390407562256},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.35360389947891235},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2619381546974182},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24847754836082458},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.1964760422706604},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.10259687900543213},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008079","descriptor_name":"Lipoproteins, VLDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013429","descriptor_name":"Sulfatases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1002/hep.25580","doi":"https://doi.org/10.1002/hep.25580","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hep.25580","pdf_url":null,"source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},{"id":"pmid:22234891","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22234891","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology (Baltimore, Md.)","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/2e23f5a9-dc73-4653-958c-dbdc290b4dbe","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/2e23f5a9-dc73-4653-958c-dbdc290b4dbe","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hassing, H C, Mooij, H, Guo, S, Monia, B P, Chen, K, Kulik, W, Dallinga-Thie, G M, Nieuwdorp, M, Stroes, E S G & Williams, K J 2012, 'Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia', Hepatology (Baltimore, Md.), vol. 55, no. 6, pp. 1746-1753. https://doi.org/10.1002/hep.25580","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:2663126","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3345297","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3345297","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3345297/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Hepatology","raw_type":"Text"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/e28e7fcf-d6ba-4c67-96be-57247c7a272a","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/inhibition-of-hepatic-sulfatase2-in-vivo-a-novel-strategy-to-correct-diabetic-dyslipidemia(e28e7fcf-d6ba-4c67-96be-57247c7a272a).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hepatology (Baltimore, Md.), 55(6), 1746 - 1753. John Wiley and Sons Ltd","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2663126","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3345297","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1760808015","display_name":"HSPGs as remnant receptors: critical role in diabetic postprandial dyslipidemia","funder_award_id":"R01HL094277","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G2321188285","display_name":"Screens for novel compounds to correct diabetic postprandial dyslipidemia","funder_award_id":"R01HL093321","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1502524639","https://openalex.org/W1778185206","https://openalex.org/W1966190991","https://openalex.org/W1969349787","https://openalex.org/W1977335231","https://openalex.org/W1978370459","https://openalex.org/W1984855900","https://openalex.org/W1991172636","https://openalex.org/W1996795546","https://openalex.org/W1999469165","https://openalex.org/W2001507450","https://openalex.org/W2002659444","https://openalex.org/W2020659754","https://openalex.org/W2024575792","https://openalex.org/W2028938330","https://openalex.org/W2041091423","https://openalex.org/W2047465218","https://openalex.org/W2065352574","https://openalex.org/W2084742654","https://openalex.org/W2095949497","https://openalex.org/W2097699954","https://openalex.org/W2101796063","https://openalex.org/W2113266466","https://openalex.org/W2115570439","https://openalex.org/W2130886644","https://openalex.org/W2145073911","https://openalex.org/W2146131194","https://openalex.org/W2149433053","https://openalex.org/W2154704322","https://openalex.org/W2157187496","https://openalex.org/W2157280645","https://openalex.org/W2159504081","https://openalex.org/W2160390128","https://openalex.org/W2164324917","https://openalex.org/W2167309844","https://openalex.org/W2171803589","https://openalex.org/W2172488527","https://openalex.org/W2187361253","https://openalex.org/W2198678228","https://openalex.org/W2331274940","https://openalex.org/W4250332773"],"related_works":["https://openalex.org/W1978370459","https://openalex.org/W4493692","https://openalex.org/W1547908284","https://openalex.org/W2081521695","https://openalex.org/W3144559233","https://openalex.org/W1870528495","https://openalex.org/W2955061844","https://openalex.org/W2294276088","https://openalex.org/W3212461928","https://openalex.org/W2169894356"],"abstract_inverted_index":{"UNLABELLED:":[0],"Type":[1],"2":[2],"diabetes":[3],"mellitus":[4],"(T2DM)":[5],"impairs":[6],"hepatic":[7,110,135],"clearance":[8],"of":[9,46,103,129,227,237,250],"atherogenic":[10],"postprandial":[11,68,242],"triglyceride-rich":[12],"lipoproteins":[13],"(TRLs).":[14],"We":[15],"recently":[16],"reported":[17],"that":[18,33,157],"livers":[19],"from":[20,38,142],"T2DM":[21,61,224],"db/db":[22,107,143,162,193],"mice":[23,62,80,108,144,163,194],"markedly":[24],"overexpress":[25],"the":[26,52,127,170,188,234],"heparan":[27,39],"sulfate":[28,36,40],"glucosamine-6-O-endosulfatase-2":[29],"(SULF2),":[30],"an":[31,259],"enzyme":[32],"removes":[34],"6-O":[35],"groups":[37],"proteoglycans":[41],"(HSPGs)":[42],"and":[43,125,240],"suppresses":[44],"uptake":[45],"TRLs":[47],"by":[48,115,177],"cultured":[49],"hepatocytes.":[50],"In":[51],"present":[53],"study,":[54],"we":[55],"evaluated":[56],"whether":[57],"Sulf2":[58,76,87,104,111,165,167,184,214,256],"inhibition":[59,226,257],"in":[60,63,121,134,152,161,192,223,252],"vivo":[64,253],"could":[65],"correct":[66],"their":[67,238],"dyslipidemia.":[69,265],"Selective":[70],"second-generation":[71],"antisense":[72],"oligonucleotides":[73],"(ASOs)":[74],"targeting":[75],"were":[77,81],"identified.":[78],"Db/db":[79],"treated":[82],"for":[83,203,213],"5":[84],"weeks":[85],"with":[86],"ASO":[88,105,147,168,185,205],"(20":[89],"or":[90,98],"50":[91],"mg/kg":[92],"per":[93],"week),":[94],"nontarget":[95],"(NT)":[96],"ASO,":[97],"phosphate-buffered":[99],"saline":[100],"(PBS).":[101],"Administration":[102],"to":[106,119,131,254,262],"suppressed":[109],"messenger":[112],"RNA":[113],"expression":[114],"70%-80%":[116],"(i.e.,":[117],"down":[118],"levels":[120,176],"nondiabetic":[122,180],"db/m":[123],"mice)":[124],"increased":[126],"ratio":[128],"tri-":[130],"disulfated":[132],"disaccharides":[133],"HSPGs":[136],"(P":[137],"<":[138,216],"0.05).":[139],"Hepatocytes":[140],"isolated":[141],"on":[145,164],"NT":[146,204],"exhibited":[148],"a":[149,228,247],"significant":[150],"impairment":[151],"very-low-density":[153],"lipoprotein":[154],"(VLDL)":[155],"binding":[156],"was":[158],"entirely":[159],"corrected":[160],"ASO.":[166],"lowered":[169],"random,":[171],"nonfasting":[172],"plasma":[173,189],"triglyceride":[174],"(TG)":[175],"50%,":[178],"achieving":[179],"values.":[181],"Most":[182],"important,":[183],"treatment":[186],"flattened":[187],"TG":[190],"excursions":[191],"after":[195],"corn-oil":[196],"gavage":[197],"(iAUC,":[198],"1,500":[199],"\u00b1":[200,208],"470":[201],"mg/dL\u00b7h":[202],"versus":[206],"160":[207],"40":[209],"mg/dL":[210],"\u00b7":[211],"h":[212],"ASO\\P":[215],"0.01).":[217],"CONCLUSIONS:":[218],"Despite":[219],"extensive":[220],"metabolic":[221,264],"derangements":[222],"mice,":[225],"single":[229],"dys-regulated":[230],"molecule,":[231],"SULF2,":[232],"normalizes":[233],"VLDL-binding":[235],"capacity":[236],"hepatocytes":[239],"abolishes":[241],"hypertriglyceridemia.":[243],"These":[244],"findings":[245],"provide":[246],"key":[248],"proof":[249],"concept":[251],"support":[255],"as":[258],"attractive":[260],"strategy":[261],"improve":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016487555","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
